Blepharitis associated with increased prevalence of lower eyelid ectropion: Study Jacinthlyn Sylvia14 March 2025 9:00 PM ISTA recent retrospective study published in the Seminars in Ophthalmology highlighted a notable association between blepharitis and lower eyelid...
Lupin, Scope Ophthalmics Ireland ink pact to market Optase range of products in Mexico Ruchika Sharma2 Oct 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics Ireland (SCOPE) for the...
Natural therapy shows promise for dry-eye disease Dr. Kamal Kant Kohli5 Feb 2024 5:00 AM ISTResearchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a...
Twice-daily lotilaner ophthalmic solution effective treatment of patients with Demodex blepharitis Dr. Shravani Dali26 Jun 2023 8:00 PM ISTTwice-daily treatment with lotilaner ophthalmic solution,holds promise for the effective treatment of patients with Demodex blepharitis suggests a new...
Viatris acquires Famy Life Sciences ophthalmology business for Rs 2,500 crore Ruchika Sharma8 Nov 2022 1:30 PM ISTViatris is taking over a business consisting of a strong ophthalmic portfolio of phase 3 clinical assets in diseases such as dry eye, presbyopia, and...
Topical ophthalmic antibiotics not tied with increased adverse neonatal outcomes: Study Dr. Shravani Dali1 Jun 2022 9:45 AM ISTTreatment of chalazia, hordeola, blepharitis, and bacterial conjunctivitis with topical ophthalmic antibiotics does not increase the risk of adverse...
Augmented Intense Pulse Light therapy may improve Meibomian gland dysfunction and dry eye disease MD Editorial Team4 Dec 2021 9:00 AM ISTSandy Zhang-Nunes and colleagues discovered that intense pulsed light (IPL) has shown great potential in the treatment of refractory Meibomian gland...
Dupilumab may Raise Risk of Ocular Disease in Atopic Dermatitis Patients: Study Josepha James8 Jun 2021 9:15 AM ISTDupilumab is the first human monoclonal antibody approved for the treatment of atopic dermatitis (AD). However, a recent study suggests that the use...
